Related Experiment Video

Updated: Jun 6, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

A practical guide to pediatric multiple sclerosis

P Huppke1, J Gärtner

  • 1Department of Pediatrics and Pediatric Neurology, Georg August University, Faculty of Medicine, Robert-Koch-Straße 40, Göttingen, Germany. phuppke@med.uni-goettingen.de

Neuropediatrics
|November 19, 2010
PubMed

Insights

Recent advances offer new insights into pediatric multiple sclerosis (MS). This review covers diagnosis, differential diagnosis, and treatment for children with MS.

Area of Science:

  • Neurology
  • Pediatrics

Background:

  • Significant advancements in understanding pediatric multiple sclerosis (MS) have occurred over the last decade.
  • Pediatric MS presents unique diagnostic and therapeutic challenges compared to adult-onset MS.

Purpose of the Study:

  • To consolidate current knowledge on pediatric multiple sclerosis for neurologists and pediatric neurologists.
  • To provide a comprehensive overview of diagnosis, differential diagnosis, and therapeutic strategies for pediatric MS.

Main Methods:

  • Literature review focusing on studies published in the last 10 years.
  • Synthesis of information relevant to the clinical management of pediatric MS.

Main Results:

  • Increased understanding of the epidemiology and clinical presentation of MS in children.
  • Evolving diagnostic criteria and improved imaging techniques for pediatric MS.
  • Emerging therapeutic options and treatment guidelines tailored for pediatric MS patients.

Conclusions:

  • Pediatric multiple sclerosis requires specialized diagnostic and management approaches.
  • Continued research is crucial for optimizing long-term outcomes in children with MS.
  • This review serves as a valuable resource for clinicians managing pediatric MS.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...